Wellgistics Health publishes shareholder letter outlining vertical integration, blockchain strategy

• Wellgistics Health on May 21, 2026 published a shareholder letter outlining a strategy centered on vertical integration across the pharmacy channel, supported by blockchain-based infrastructure via its PharmacyChain platform and EinsteinRx AI.
• The letter links recently announced transactions to building a tokenized healthcare data layer, a patient verification layer, and a direct-to-patient channel to capture real-world adherence and biometric data.
• Management framed the approach as positioning the company to provide “essential infrastructure” for healthcare data exchange, with an emphasis on pharmacies as a key source of longitudinal patient behavior data across its network of 6,500 pharmacies and more than 200 manufacturers.
• The letter also referenced a planned share restructuring and a new CUSIP as part of the next phase of growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-024823), on May 21, 2026, and is solely responsible for the information contained therein.